Associated Papers
Development and Characterisation of a New Patient-Derived Xenograft Model of AR-Negative Metastatic Castration-Resistant Prostate Cancer.
Turnham DJ et al.
Cells, 2024
Pathways to precision medicine in smoking cessation treatments.
Chen LS et al.
Neuroscience Letters, 2018
Novel human genome variants associated with alcohol use disorders identified in a Lithuanian cohort.
Baronas K et al.
Acta Medica Lituanic, 2018
Identification of Deleterious SNPs and Their Effects on Structural Level in CHRNA3 Gene.
Chandramohan V et al.
Biochemical Genetics, 2015
Rare missense variants in CHRNB3 and CHRNA3 are associated with risk of alcohol and cocaine dependence.
Haller G et al.
Human Molecular Genetics, 2014
Introduction to deep sequencing and its application to drug addiction research with a focus on rare variants.
Wang S et al.
Molecular Neurobiology, 2014
Habenular expression of rare missense variants of the β4 nicotinic receptor subunit alters nicotine consumption.
Slimak MA et al.
Frontiers in Human Neuroscience, 2014
Rare missense variants in CHRNB4 are associated with reduced risk of nicotine dependence.
Haller G et al.
Human Molecular Genetics, 2012
The genetics of substance dependence.
Wang JC et al.
Annual Review of Genomics and Human Genetics, 2012
Markers in the 15q24 nicotinic receptor subunit gene cluster (CHRNA5-A3-B4) predict severity of nicotine addiction and response to smoking cessation therapy.
Sarginson JE et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics, 2011
The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans.
Saccone NL et al.
Cancer Research, 2009
Select a paper to view details